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Abstract
We surveyed human immunodeficiency virus (HIV) subtype distribution from peripheral blood
mononuclear cells (PBMCs) collected in 1995 from 24 HIV-1-infected Kenyan residents (specimens from
predominantly male truck drivers and female sex workers near Mombasa and Nairobi). Processed lysates from
the PBMC samples were used for env amplification, directly sequenced, and analyzed by phylogenetic
analysis. Envelope amplification products were also used for analysis in a polymerase chain reaction (PCR)-
based assay, called the combinatorial melting assay (COMA). Results of the two tests were compared for
assignment of subtype for this Kenyan cohort. The COMA, a PCR capture technique with colorimetric signal
detection, was used with HIV reference subtype strains as well as regional (East Africa) HIV strains for
subtype identification. Performance of the COMA was at 100% concordance (24 of 24) as compared with
DNA sequencing analysis. Phylogenetic analysis showed 17 isolates to be subtype A, 3 subtype D, and 4
subtype C viruses. This may represent an increase in subtype C presence in Kenya compared with previously
documented reports. The COMA can offer advantages for rapid HIV-1 subtype screening of large populations,
with the use of previously identified regional strains to enhance the identification of local strains. When more
detailed genetic information is desired, DNA sequencing and analysis may be required.
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Genetic Analysis of Human Immunodeficiency Virus Type 1
Strains in Kenya: A Comparison Using Phylogenetic Analysis
and a Combinatorial Melting Assay
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ABSTRACT
We surveyed human immunodeficiency virus (HIV) subtype distribution from peripheral blood mononuclear
cells (PBMCs) collected in 1995 from 24 HIV-1-infected Kenyan residents (specimens from predominantly
male truck drivers and female sex workers near Mombasa and Nairobi). Processed lysates from the PBMC
samples were used for env amplification, directly sequenced, and analyzed by phylogenetic analysis. Envelope
amplification products were also used for analysis in a polymerase chain reaction (PCR)-based assay, called
the combinatorial melting assay (COMA). Results of the two tests were compared for assignment of subtype
for this Kenyan cohort. The COMA, a PCR capture technique with colorimetric signal detection, was used
with HIV reference subtype strains as well as regional (East Africa) HIV strains for subtype identification.
Performance of the COMA was at 100% concordance (24 of 24) as compared with DNA sequencing analy-
sis. Phylogenetic analysis showed 17 isolates to be subtype A, 3 subtype D, and 4 subtype C viruses. This may
represent an increase in subtype C presence in Kenya compared with previously documented reports. The
COMA can offer advantages for rapid HIV-1 subtype screening of large populations, with the use of previ-
ously identified regional strains to enhance the identification of local strains. When more detailed genetic in-
formation is desired, DNA sequencing and analysis may be required.
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INTRODUCTION
THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) globalepidemic is currently thought to be composed of at least
10 phylogenetically distinct group M subtypes, designated A
through J, and group O viruses.1±4 Worldwide, and especially
in African countries, where the epidemic is oldest, multiple sub-
types predominate.5,6 The surveillance and documentation of
strains, both established as well as newly disseminated in coun-
tries, are important for epidemiological tracking, diagnostic
testing methodologies, protection of the blood supply, vaccine
development, and field trials.7 Several techniques have been
used to determine subtypes of HIV-1: (1) nucleotide sequenc-
ing,3,4 (2) the enzyme immunoassay utilizing peptides from the
variable 3 region (V3) of the gp120 region from HIV-1,8±10 (3)
the heteroduplex mobility assay (HMA),11,12 and (4) subtype
classification by polymerase chain reaction (PCR).13 While all
of these methods have particular advantages and disadvantages,
nucleotide sequencing is the most definitive and informative.
However, compared with sequencing, the HMA has been
demonstrated to be reliable for subtyping.14 The most frequently
sequenced portion of the HIV-1 genome is the V3 and flank-
ing regions of gp120 in the env gene.4 This is due to the bio-
logical importance of this area15±19 as well as to the large num-
bers of strains sequenced for this region and available for
phylogenetic comparison in the Los Alamos National Labora-
tory HIV database.4 Sequence analysis of this gene region has
been shown to provide accurate phylogenetic relationships, us-
ing most of the commonly available methods for inferring phy-
logenetic relationships.20,21 To determine the subtype distribu-
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tion of HIV strains in truck drivers and sex workers near Mom-
basa and Nairobi, Kenya, and to better understand their contri-
bution to the dissemination and mixing of subtypes, specimens
from HIV-infected persons were obtained and sequenced di-
rectly from PCR fragments from the envelope gene. Phyloge-
netic analysis of the sequences was compared with the results
produced by a new combinatorial melting assay (COMA),22 uti-
lized here for HIV-1 subtype identification. The COMA sub-
types an amplification product that encompasses the env region
we sequenced, plus approximately 100 bp upstream and 100 bp
downstream. The utility and performance characteristics of the
two techniques are discussed.
MATERIALS AND METHODS
Specimens and isolation of viral DNA
Twenty-four HIV-1 specimens were obtained in 1995 from
participants in a Kenyan sexual transmission cohort study, near
Mombasa and Nairobi. The individuals were predominantly
male truck drivers and female sex workers. The peripheral blood
mononuclear cell (PBMC) processing and PCR amplification
of the DNA lysates were as previously described,23 except that
the primary amplification primers for DNA sequencing were
MK369 (5 9 -TGGAGCCAGTAGATCCTAGACTAGAGCC-
CT) and MK616 (59 -AATGGTGAGTATCCCTGCCTAAC-
TCTATT) and the nested amplification primers for DNA se-
quencing were MK650 (5 9 -AATGTCAGCACAGTACAA-
TGTACAC) and MK601 (5 9 -TTCTCCAATTGTCCCTCATA-
TCTCCTCCTCCA). The primary amplification primers uti-
lized for the COMA PCR product were either MK369/MK616,
MK603 (5 9 -CAGAAAAATGGTGGGTCACAGTCTATTAT-
GGGGTACCT) and MK602 (5 9 -GCCCATAGTGCTTCCT-
GCTGCTCCCAAGAACC), or ED5/ED12.11 Nested amplifi-
cation primers2,22 for the COMA PCR products were LK1/
LK2.22
DNA sequencing
PCR-amplified products were purified by the Qiagen PCR
purification kit (Qiagen, Chatsworth, CA). Purified DNA was
sequenced according to the ABI PRISM dye terminator cycle
sequencing Ready Reaction kit (Applied Biosystems/Perkin-
Elmer, Foster City, CA). Sequencing primers used were vari-
ous combinations of the PCR primers (MK616, MK650) and
an internal sequencing primer KR207 (5 9 -CTGTTAAATG-
GCAGTCTAGC).
Phylogenetic analysis
The sequences were manually aligned with the sequence ed-
itor function of the Genetic Data Environment (GDE) pack-
age24 and positions where gaps occurred were removed from
analysis, leaving 327 nucleotide sites. Percentage diversity was
calculated with the pdist function of the Molecular Evolution
Genetic Analysis (MEGA) program.25 Phylogenetic analysis
was accomplished with PHYLIP (Phylogeny Inference Pack-
age)26 for both neighbor-joining and maximum likelihood trees.
Pairwise evolutionary distances were estimated for the neigh-
bor-joining trees by using the maximum likelihood option as
the evolutionary model in the dnadist program. Utilizing the
consense program, a consensus tree was developed from the
500 bootstrapped, neighbor-joining trees.
Nucleotide sequence accession numbers
The GenBank accession numbers for the Kenyan sequences
reported in this study are listed in Table 1.
COMA
The COMA was performed by two of us (L.K. and S.S.) as
previously described,22 with modifications of the reference
strains used. Briefly, antisense, single-stranded DNAs (ssD-
NAs) were generated for reference subtypes A, B, C, and D by
asymmetrical PCR, with biotinylation of one of the primers fa-
cilitating capture to streptavidin-coated plates. Reference and
regional strains used for the different subtypes (followed by
each GenBank accession number) were as follows: A
(92KEML1048:AF103913, 91KEMCH9727:AF103910, 91K-
EMCHI96:AF103911, and 92KEML639:AF103914), B (BR20:
U08797 and TH14:U08801), C (SM145:L22946, DJ259:
L22940, and MW6510:L15733), and D (91KEML22:AF10312,
89KEML203:AF103909, UG21:U27399, and UG46:U08809).
Reference PCR products from the same subtype were combined
to form reference pools and placed in rows of the microtiter
plate. Complementary sense-stranded molecules from the
Kenyan DNA were produced by asymmetrical PCR with digox-
igenin labeling. These samples were placed in the microtiter
plate columns, allowing heteroduplex formation between the
Kenyan DNA and reference subtype DNA. The subtype was
determined by a colorimetric immunoassay using alkaline phos-
phatase-conjugated antibody against digoxigenin. The correct
subtype was determined by the comparative absorbance mea-
surement, rounded to the first decimal place, being higher than
any other by a factor of at least two.
RESULTS
PCR amplification and nucleotide analysis
PCR amplification of the C2V3 region of the env gene was
performed with two sets of primers in a nested fashion in two
separate PCRs. Nucleotide sequences were obtained directly
from the PCR product and aligned for homologous positions,
and a neighbor-joining phylogenetic tree was constructed (Fig.
1). Seventeen of the Kenyan sequences clustered within the sub-
type A group, 4 with subtype C, and 3 with subtype D. The
same subtype classifications were obtained with a tree con-
structed with the maximum likelihood program (data not
shown). Two pairs of sequences (KEML1/KEQRS1, KETK5/
KEML4) clustered together with bootstrap support greater than
70% (Fig. 1) as well as in the maximum likelihood tree. These
sequences are from female sex workers and a female sex
worker/male truck driver, respectively (see caption to Fig. 1).
Whether these pairs represent epidemiologically linked infec-
tions is unknown, yet the sequences within each pair being de-
rived from individuals residing in different cities (Mombasa and
Nairobi) suggests some infection links between these commu-
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nities. Subtypes A and C are represented in these two pairs, and
all three subtypes found in this study have previously been re-
ported in Kenya.6,27,28
The percentage diversity of the nucleotide sequences was
calculated for the Kenyan taxa in Fig. 1. The mean genetic dis-
tance among Kenyan subtype A sequences is 13.2%, while the
subtype C distance is 11.2% and the subtype D distance is
10.7%. An alignment of the predicted amino acid sequences for
the 24 Kenyan sequences is depicted in Fig. 2. All are com-
pared with subtype-specific consensus sequences from the Los
Alamos HIV database.4
The GPGQ tetrameric tip of the V3 loop was predominant
in all three subtypes, with the exception of two type As
(KESHH1, KEX1) and one type D (KEQRS3) having GPGR.
Positively charged amino acids at positions 11 and 25 of the
V3 loop, generally believed to be associated with a syncytium-
inducing phenotype,29 were absent in all of the Kenya se-
quences. This would be expected for subtype A strains, but pos-
itively charged amino acids at one or two of these positions
usually make up the majority of published African type D
strains.6,14,30 One explanation could be that these Kenyan
strains may be from individuals in an early stage of infec-
tion,31,32 although clinical data are not available.
COMA and comparison with sequencing
PCR amplification of the C2V4 region of the env gene was
performed with one set of primers and subsequently sent to two
of us (L.K. and S.S.)22 for secondary amplification and COMA
testing (see Materials and Methods). Table 1 lists the COMA
results by relative absorbance densities of the 24 Kenyan spec-
imens in comparison with the subtype determined by sequenc-
ing and phylogenetic analysis. All specimens are in agreement
between the two methods, corresponding to a 100% concor-
dance (24 of 24).
DISCUSSION
COMA versus sequencing analysis for HIV-1 
subtype identification
Along with investigating the distribution of strains among
the highly mobile cohort of truck drivers and sex workers, we
compared the accuracy of the COMA with DNA sequencing
and subsequent phylogenetic analysis and adapted the COMA
in a region-specific fashion for subtyping HIV strains from
Kenya. Phylogenetic analysis was performed on a genomic re-
gion within and approximately 200 bp shorter than the PCR
fragment used in the COMA. The extensive use of this region
by us and others for accurate subtyping allowed the utility of
sequencing this shorter fragment for comparisons with the
COMA results. The complete concordance for this Kenyan
HIV-1 sampling between the two methodologies (100%, 24 of
24) demonstrated that the two env regions could be compared
reliably by these methods (although the sample size is relatively
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TABLE 1. COMA VERSUS SEQUENCING SUBTYPING RESULTS OF THE STUDY SPECIMENS
Relative absorbance densities
(490 nm) of DNA heteroduplexes
formed by complementary ssDNA
Subtype
GenBank





Isolate numbers A B C D by COMA sequencing
KEMCH1 AF103916 1.00 0.12 0.10 0.13 A A
KEMCH3 AF103917 1.00 0.09 0.13 0.11 A A
KEMCH4 AF103918 1.00 0.13 0.13 0.13 A A
KEML3 AF103921 1.00 0.08 0.09 0.10 A A
KEML4 AF103922 1.00 0.08 0.08 0.08 A A
KEML5 AF103923 1.00 0.17 0.17 0.21 A A
KEML6 AF103924 1.00 0.20 0.13 0.48 A A
KEQRS2 AF103926 1.00 0.17 0.22 0.24 A A
KEQRS4 AF103928 1.00 0.11 0.10 0.15 A A
KETDP1 AF103930 1.00 0.12 0.14 0.18 A A
KETDP2 AF103931 1.00 0.11 0.13 0.13 A A
KETK2 AF103934 1.00 0.07 0.11 0.10 A A
KETK3 AF103935 1.00 0.11 0.12 0.12 A A
KETK4 AF103936 1.00 0.10 0.16 0.14 A A
KETK5 AF103937 1.00 0.07 0.17 0.08 A A
KESHH1 AF103929 1.00 0.07 0.04 0.11 A A
KEX1 AF103938 1.00 0.07 0.09 0.10 A A
KEML1 AF103919 0.27 0.12 1.00 0.18 C C
KEQRS1 AF103925 0.28 0.28 1.00 0.23 C C
KETDP3 AF103932 0.19 0.26 1.00 0.18 C C
KETK1 AF103933 0.51 0.07 1.00 0.24 C C
KEMCH2 AF103916 0.26 0.46 0.11 1.00 D D
KEML2 AF103920 0.09 0.08 0.11 1.00 D D
KEQRS3 AF103927 0.11 0.08 0.12 1.00 D D
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FIG. 1. Phylogenetic analysis of 24 HIV-1 DNA specimens obtained from individuals in Kenya. Analysis is based on 327
alignable positions (positions in alignment containing one or more gaps are excluded from analysis) in the C2V3 region of the
HIV-1 env gene with the simian immunodeficiency virus SIVcpzgab as outgroup. Los Alamos HIV Database subtype sequences
from A, B, C, D, E, F, G, and H are included to facilitate subtype clustering of the Kenyan sequences. The Kenyan sequences
determined in this study (boldface with a KE prefix, isolation date of 1995) are designated as follows: MCH, female sex work-
ersÐ region unknown; ML, female sex workers from Nairobi; QRS, female sex workers from Mombasa; TDP, male truck dri-
vers near Nairobi; TK, male truck drivers near Mombasa; SHH, male sexually transmitted disease patient; X, unknown. For clar-
ity, those originating from Mombasa have an -m suffix and those from Nairobi have an -n suffix. The numbers at the branch
points indicate the percentage of times the branch was preserved in the 500 bootstrap replications. Only bootstrap proportions
. 70% are shown. The large letters indicate A±H subtypes.
small) and supports the use of the COMA to subtype previously
unknown samples. A key feature of the COMA is its flexible
use of multiple strains from each subtype for detection of the
unknown strain. Utilization of strains found in the geographic
region of interest as reference strains is a customization of the
more general COMA, which is run with worldwide reference
strains for subtyping.22 Specimens from subtypes A and D,
which have been reported to predominate in Kenya and Uganda,
were used in the cocktail of reference strains. The Kenyan ref-
erence strains were from female sex workers, isolated from
1989 to 1992. Further refinement of signal-to-noise ratios for
the COMA may be assisted by addition of more recently sub-
typed specimens to the respective subtype reference pool. As
we demonstrated here, a population-based study could be per-
formed using the COMA technology for initial subtype identi-
fication, without DNA sequencing. Ambiguous or cross-react-
ing specimens (i.e., subtype recombinants or dual infections)
could then be sequenced for further identification, if needed.
In addition, the COMA can be used to systematically mon-
itor change in subtype distribution over time in large popula-
tion-based surveys. Immunology-based assays such as peptide-
binding enzyme immunoassays (EIAs) have been effective
where the epidemic was relatively new and, consequently, the
diversity within subtypes was low, e.g., in Thailand.9 In regions
where the epidemic is older and people have been infected for
longer periods, the with-in person distribution of quasispecies
is more complex, and the host immune system has responded
to many antigenically distinct variants. These samples typically
have a large degree of cross-reactivity in serological peptide-
based assays. Therefore, the HMA11,14 and COMA techniques,
as demonstrated previously22 and in this study, are more reli-
able for subtype assignment. Subtype analysis with the HMA
typically uses two reference strains per subtype, while the mi-
crotiter format of the COMA allows many reference strains to
be used with no increase in the number of wells. Sequencing
and subsequent phylogenetic analysis, although more time con-
suming, is generally considered the ª gold standard.º The
COMA has the advantages of using a format typical of that
widely used in EIA technology, requiring little equipment be-
yond a thermocycler for PCR, and being easy to interpret. The
HMA could be used as a complement to initial COMA screen-
ing by identifying major and minor quasispecies of samples that
yield indeterminate COMA results. Alternatively, or as the next
step, the PCR-amplified specimen could be sequenced for de-
finitive typing, mutation analysis, amino acid sequence predic-
tion, and identification of recombinant viruses.
Kenyan HIV-1 subtypes
HIV-1 subtyping has been an important part of the surveil-
lance and characterization of HIV strains for designing vaccine
strategies prior to conducting vaccine field trials. Many African
countries harbor a large variety of subtypes represented in the
global epidemic. In particular, the Central and East African
countries, which includes Kenya, compose that region of the
continent where most of the subtypes have been reported.14,33
Our interest in tracking the spread of HIV-1 subtypes in this
area led us to obtain and analyze 24 specimens from a Kenyan
sex worker/truck driver cohort. The finding that most (17 of 24)
of these strains grouped with subtype A and a minority with
subtype D (3 of 24) is similar to previously published reports
of Kenyan sequences6 and is also consistent with the rapid
spread of subtype A in Central Africa.14 Subtype C (4 of 24 in
this study) is also well established in several southern African
countries,7,34,35 as well as in India.36 The spread of this sub-
type to other countries includes China,37 Malaysia,38 Russia,39
England,40 and the United States (P. Sullivan, Centers for Dis-
ease Control [CDC, Atlanta, GA], unpublished data, 1998). The
United Nations Program on AIDS (UNAIDS, Geneva, Switzer-
land) has identified subtypes A and C as the most prevalent
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FIG. 2. Amino acid alignment of the env C2V3 regions of the Kenyan strains compared with subtype A, C, and D consensus
sequences.20 Kenyan descriptive names are as listed in the caption to Fig. 1. A dash (±) indicates identity with the A, C, or D
consensus sequence and a period (.) depicts a deletion.
group M strains worldwide and has organized collaborative
international studies for better sampling and characterization
of these subtypes.41 The identification of the C subtype in
these Kenyan residents is further documentation of its con-
tinuing spread. Previous Kenyan HIV subtype sampling stud-
ies6,27,28 for specimens collected from 1991 to 1994 had
demonstrated only one subtype C strain. Although the sam-
pling numbers are relatively small, the increased number of
subtype C virus strains identified here could indicate an in-
creasing prevalence of subtype C HIV strains in Kenya. It at
least establishes that the initial report28 of a subtype C virus
in Kenya was not spurious and that subtype C viruses are be-
ing transmitted in this region.
The worldwide trend toward an increase in multiple subtypes
in regions where only a few previously predominated is typi-
cally associated with increased travel and demographic shifts.42
Truck drivers involved in this study transport goods along the
trans-African highway, beginning in Mombasa (a major re-
gional seaport), with final destinations in Uganda, Tanzania,
Rwanda, Burundi, eastern Zaire, and southern Sudan.43 The dri-
vers are on the road for many weeks or months and have fre-
quent contact with female sex workers along the route. Sex
workers are also mobile along the truck route, sometimes ac-
companying drivers. Both drivers and sex workers have high
rates of HIV-1 infection. Thus, these individuals may be ex-
posed to HIV-1 subtypes from a wide geographic area and could
provide a means of introducing new HIV-1 subtypes (subtype
C in this case) into new geographic areas. The observation that
two (A and C) of the three subtypes found here have phyloge-
netically linked sequences from residents of different Kenyan
cities may further indicate the effectiveness of spread by the
high-risk behavior within these risk groups.
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